Navigation Links
A smart way of using testosterone to prevent muscle wasting
Date:7/30/2013

New Australian research suggests that a small dose of testosterone directed solely to the liver stimulates protein synthesis, likely preventing muscle loss and wasting, and potentially promoting muscle growth. The researchers believe they have developed a safe and effective treatment for men and women, that could prevent the muscle wasting associated with many chronic diseases and with ageing.

Dr Vita Birzniece and Professor Ken Ho, from Sydney's Garvan Institute of Medical Research, showed in healthy postmenopausal women that a small dose of the male hormone testosterone prevented protein wasting. The pure crystalline testosterone, taken orally, went straight to the liver, and the dose (40mg/day) was small enough to ensure it was contained there, with no spillover to the bloodstream and other organs. The findings are now published online in the European Journal of Endocrinology.

This new approach allows people to benefit from testosterone's ability to stimulate muscle growth and increase muscle strength. At the same time, it sidesteps the side effects of testosterone when given in the usual way administered in much larger doses by injection, gel or patch through the skin.

When testosterone is injected, it goes directly to peripheral tissues and major organs, including the brain. This can cause unwanted side effects, including aggressive behaviour and heightened libido. It can also cause heart damage, and in women induce facial hair and a deeper voice.

When taken orally in a small dose, it is absorbed through the gut and goes straight to and acts on the liver, where it is also broken down, so that no other tissue or organ is exposed.

"The novel aspect of this research is that only the liver gets tickled with testosterone. It is a new way of using an old hormone," said Professor Ken Ho.

"This is a great advantage because it avoids the unpleasant behavioural effects of high doses of testosterone injected into the bloodstream and the masculinising effects in women."

"We saw that low dose testosterone, taken orally, had the same magnitude of effect on whole body protein metabolism as when it is injected in larger doses in men," added Dr Vita Birzniece.

"This is really hopeful, because if we can see the same effect on protein metabolism at this stage, we believe it will translate into the same increase in muscle mass that we see from testosterone delivered systemically, yet avoiding all the unpleasant side effects."

The next step will be to recruit healthy men with lower testosterone levels, as well as frail people, such as patients with kidney failure.

If the researchers can see the same effect on protein metabolism in several categories of frail people, they will design a placebo controlled study, investigating the effect of oral testosterone on muscle mass and function. If the results are positive, they will recommend that this would be a novel safe treatment for muscle wasting.

If we can reduce muscle wasting in frail elderly people, this would prevent many falls, and therefore osteoporotic fractures," added Professor Ho.


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Garvan Institute of Medical Research
Source:Eurekalert

Related medicine news :

1. PolyU Design Students Win 2nd Prize in National Competition With “Smart Pill Box for Elderly”
2. Phronetic Technologies Announces First Prenatal Smart Wearable Technology; StimElation is Poised for Production
3. Health and Human Services Professionals to Collaborate and Learn Together at Netsmart CONNECTIONS2013 Conference
4. Compounds outsmart solid tumors malfunctioning machinery
5. Interactive Pharma Apps: Sell More, Faster, Smarter
6. Spain Tech Hub welcomes the launch of Firefox smart phone
7. Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Now Offers Clients Ability to Receive Updates and Access Records on Smartphones
8. Lumosity Data Ranks America’s Smartest Cities
9. Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinsons disease
10. Smart Education and Learning Market to Reach $220.0 Billion by 2017 - New Report by MarketsandMarkets
11. SMARTMD Launches SmartPAY Online Billing Solution for Medical Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: